Our growing product range
Our ever-growing product range to designed to simplify and enhance the management of each therapy area, ensuring accessibility for all. The full range is cost-effective without compromising on quality. With input from clinical pharmacists, nurses, and consultants they help us to constantly improve our range and support patient needs. Selected for both quality and competitive pricing, they offer potential savings for numerous ICBs and Health Boards.
Diabetes
Our Diabetes range includes the most cost-effective pen needles on the Drug Tariff¹, and a range of meters that're recommended on the NHS England's Diabetes Framework.
Find out moreContinence
The SpiritCare Continence range provides users with high quality materials designed to provide security, comfort and ease-of use, giving patients confidence to manage their health condition.
Find out moreWoundcare
While woundcare is a typically complex and costly category, our product range is designed to suit most patient care needs and is both simple and cost effective.
Find out moreActive Implementation™
A full, end to end process that ensures new formularies or guidelines are implemented successfully and all without causing disruption within the system. Making use of our Active Implementation™ service has been proven to deliver 700% greater savings than when leaving prescription changes to be managed at practice level without support.²
Find out moreHow does Active Implementation™ work?
All of our diabetes, continence and woundcare product ranges are inclusive of free implementation. We implement our products with the aim of saving you time, money, and resources. Watch the video below to find out more about Active Implementation™.
Find out how much you could save with Active Implementation™
See you how much you could save by prescribing our products
Try our cost calculator below. Based on the products we have available in our portfolio it will demonstrate how much money we can potentially save your ICB/ICS, Health Board or Local Commissioning Group.
This is an overview of the savings across the diabetes range, which are ready to go and easy to implement products. We can also look at savings for individual products within the prescribing data.
As well as highlighting the therapy areas where spend can be significantly reduced, we have also included Quick Wins savings, which are ready to go, easy to implement, minimal resource dependent products.
How much could you save?
Aneurin Bevan HB
Ayrshire and Arran
Bath and North East Somerset, Swindon and Wiltshire ICB
Bedfordshire, Luton and Milton Keynes ICB
Belfast Area
Betsi Cadwaladr University HB
Birmingham and Solihull ICB
Black Country ICB
Borders
Bristol, North Somerset and South Gloucestershire ICB
Buckinghamshire, Oxfordshire and Berkshire West ICB
Cambridgeshire and Peterborough ICB
Cardiff and Vale University HB
Cheshire and Merseyside ICB
Cornwall and The Isles of Scilly ICB
Coventry and Warwickshire ICB
Cwm Taf Morgannwg HB
Derby and Derbyshire ICB
Devon ICB
Dorset ICB
Dumfries and Galloway
Fife
Forth Valley
Frimley ICB
Gloucestershire ICB
Grampian
Greater Glasgow and Clyde
Greater Manchester ICB
Hampshire and Isle of Wight ICB
Herefordshire and Worcestershire ICB
Hertfordshire and West Essex ICB
Highland
Humber and North Yorkshire ICB
Hywel Dda HB
Kent and Medway ICB
Lanarkshire
Lancashire and South Cumbria ICB
Leicester, Leicestershire and Rutland ICB
Lincolnshire ICB
Lothian
Mid and South Essex ICB
Norfolk and Waveney ICB
North Central London ICB
North East and North Cumbria ICB
North East London ICB
North West London ICB
Northamptonshire ICB
Northern Area
Nottingham and Nottinghamshire ICB
Orkney
Powys Teaching HB
Shetland
Shropshire, Telford and Wrekin ICB
Somerset ICB
South East London ICB
South Eastern Area
South West London ICB
South Yorkshire ICB
Southern Area
Staffordshire and Stoke-on-Trent ICB
Suffolk and North East Essex ICB
Surrey Heartlands ICB
Sussex ICB
Swansea Bay University HB
Tayside
West Yorkshire ICB
Western Area
Western Isles
Based on ICB prescribing data from Aug 2022 – Sept 2024 with a 70% switch from current prescribing to comparable products from Spirit Health.
1 Annual savings shown are correct as of GPRX data September 2023 figure based on a 70% realistic switch rate.
Get in touch today
So, if all this sounds in the spirit of how you’d like to manage your prescribing spend better, simply get in touch.